How effective is Keflex for Infection? (by duration, gender, age)

Summary:

Overall ratings: 3.1/5
Long term ratings: 0/5

This is a phase IV clinical study of how effective Keflex (cephalexin) is for Infection and for what kind of people. The study is created by eHealthMe from 58 Keflex users and is updated continuously.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Sep, 08, 2023

58 people are studied for taking Keflex in Infection


What is Keflex?

Keflex has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 14,755 Keflex users for its effectiveness, alternative drugs and more.

What is Infection?

Infection is found to be associated with 3,001 drugs and 2,564 conditions by eHealthMe.

Overall effectiveness (number of people):

Does Keflex work for your Infection (overall)?

Long term (1+ years) effectiveness (number of people):

Does Keflex work for your Infection (long term)?

Keflex effectiveness for Infection (number of people):

Overall:
  • not at all: 4
  • somewhat: 13
  • moderate: 23
  • high: 11
  • very high: 7
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 0
  • high: 0
  • very high: 0

Gender of people who take Keflex for Infection *:

  • female: 62.07 %
  • male: 37.93 %

Age of people who take Keflex for Infection *:

  • 0-1: 0.0 %
  • 2-9: 3.45 %
  • 10-19: 5.17 %
  • 20-29: 20.69 %
  • 30-39: 15.52 %
  • 40-49: 17.24 %
  • 50-59: 18.97 %
  • 60+: 18.97 %

Who find Keflex more effective for Infection?

Gender of people who take Keflex for Infection *:

  • female: 55.56 %
  • male: 44.44 %

Age of people who take Keflex for Infection *:

  • 0-1: 0.0 %
  • 2-9: 5.5600000000000005 %
  • 10-19: 5.5600000000000005 %
  • 20-29: 11.11 %
  • 30-39: 22.22 %
  • 40-49: 16.67 %
  • 50-59: 22.22 %
  • 60+: 16.67 %

* Approximation only. Some reports may have incomplete information.

Do you take Keflex?

- You can start a phase IV clinical trial to monitor Keflex safety and effectiveness.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on cephalexin (the active ingredients of Keflex) and Keflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: